sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agentes antineoplásicos - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agentes antineoplásicos - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
sunitinib teva 12,5 mg capsulas duras efg
teva b.v. - sunitinib - cÁpsula dura - 12,5 mg - sunitinib 12,5 mg - sunitinib
sunitinib teva 25 mg capsulas duras efg
teva b.v. - sunitinib - cÁpsula dura - 25 mg - sunitinib 25 mg - sunitinib
sunitinib teva 50 mg capsulas duras efg
teva b.v. - sunitinib - cÁpsula dura - 50 mg - sunitinib 50 mg - sunitinib
sunitinib mylan 12,5 mg capsulas duras efg
mylan pharmaceuticals, s.l. - sunitinib - cÁpsula dura - 12,5 mg - sunitinib 12,5 mg - sunitinib
sunitinib mylan 25 mg capsulas duras efg
mylan pharmaceuticals, s.l. - sunitinib - cÁpsula dura - 25 mg - sunitinib 25 mg - sunitinib
sunitinib mylan 50 mg capsulas duras efg
mylan pharmaceuticals, s.l. - sunitinib - cÁpsula dura - 50 mg - sunitinib 50 mg - sunitinib
sunitinib dr. reddys 12,5 mg capsulas duras efg
reddy pharma iberia s.a. - sunitinib malato - cÁpsula dura - 12,5 mg - sunitinib malato 12,5 mg - sunitinib
sunitinib dr. reddys 25 mg capsulas duras efg
reddy pharma iberia s.a. - sunitinib malato - cÁpsula dura - 25 mg - sunitinib malato 25 mg - sunitinib